Dr. Harriet Margot Kluger MD
Oncologist | Medical Oncology
800 Howard Ave Yale Physicians Buil New Haven CT, 06519About
Dr. Harriet Kluger is an oncologist practicing in New Haven, CT. Dr. Kluger specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Kluger manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Education and Training
Tel Aviv Univ- Sackler Fac Of Med- Tel Aviv- Israel 1992
Tel Aviv University / Sackler Faculty of Medicine 1992
Sackler School of Medicine 1991
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Automated quantitative analysis of tissue microarrays reveals an association between high Bcl-2 expression and improved outcome in melanoma.
- Automated quantitative analysis of E-cadherin expression in lymph node metastases
- Evaluating the expression and prognostic value of TRAIL-R1 and TRAIL-R2 in breast cancer.
- Metastatic myoepithelial carcinoma of the vulva treated with carboplatin and paclitaxel.
- Characterizing disease states from topological properties of transcriptional
- Expression of tumor necrosis factor--related apoptosis-inducing ligand receptors 1 and 2 in melanoma.
- Rab33A: characterization, expression, and suppression by epigenetic modification.
- High HSP90 expression is associated with decreased survival in breast cancer.
- Increased expression of the E3 ubiquitin ligase RNF5 is associated with decreased survival in breast cancer.
- HSP90 as a marker of progression in melanoma.
- Assessing expression of apoptotic markers using large cohort tissue microarrays.
- Suppressor role of activating transcription factor 2 (ATF2) in skin cancer.
- Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer.
- Expression of Aurora A (but not Aurora B) is predictive of survival in breast cancer.
- Expression of sorafenib targets in melanoma patients treated with carboplatin, paclitaxel and sorafenib.
Clinical Trials
Treatments
- Melanoma
- Skin Cancer
- Breast Cancer
- Kidney Cancer
Professional Memberships
- Member Yale Medical Group (YMG)
Fellowships
- Yale School of Medicine
Dr. Harriet Margot Kluger MD's Practice location
Dr. Harriet Margot Kluger MD's reviews
Write ReviewRecommended Articles
- What Are the Signs and Symptoms of Multiple Myeloma?
Multiple myeloma may not show any signs during the early stages called smoldering or asymptomatic multiple myeloma. It is only after a blood or urine test that it can be diagnosed. However, as time goes by, a lot of problems and complications associated with multiple myeloma will start to show....
- What are the Side Effects of Chemotherapy?
Chemotherapy is a treatment method which makes use of certain drugs in treating cancer. It plays a number of roles in the body as part of the treatment mechanism. This may include killing cancer cells, reducing their rate of spreading or shrinking the tumors to reduce the recurrence and...
- What Conditions Do Chemotherapy Treat?
What is Chemotherapy all About?Chemotherapy is a form of treatment which involves the use of drugs to treat an illness. This definition also covers the use of antibiotics in treating diseases. Chemotherapy is mainly used in treating cancer. But there are other diseases also which can be treated...
- Is Hormone Replacement Therapy Preventing Women from Getting Mammograms?
According to a new study, the sudden drop in the rate of mammograms taken by women is due to the fear of hormone replacement therapy (HRT). Up to the year 2000, many women used to take up mammography, once every two years, as a screening method for breast cancer. By the year 2005, researchers...
- New Research Targets Stage Zero Breast Cancer
A new breast cancer diagnosis may provoke many questions. As baby boomers age, the possibility of cancer increases. Gen Xers and millennial's may also wonder about their risks, especially if breast cancer runs in the family.Receiving a diagnosis of “stage zero” breast cancer may be baffling....
- Am I at Risk for Developing Breast Cancer?
Breast cancer is identified to be a major killer of middle-aged women, and the second most common cause of death by cancer. It is estimated that one out of every eight American women living up to 95-years-old develop breast cancer. The number of deaths from breast carcinoma is now declining due to...
Nearby Providers
- Amin H. Nassar20 YORK ST NEW HAVEN CT 06510
- Dr. Christi Kim M.D.333 Cedar St. New Haven CT 06520
- Dr. Justin Persico M.D.5520 Park Avenue Trumbull Connecticut 06611
- Barbara A Burtness M.D.333 CEDAR ST NEW HAVEN CT 06510
- Dr. Ivan Stephen Lowenthal M.D.6 DEVINE ST STE 2C NORTH HAVEN CT 06473
- Dr. Charles Stewart Fuchs MD MPH333 CEDAR ST NEW HAVEN CT 06510